We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
-1.54%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$96.4B
AUM Growth
-$1.4B
(-1.4%)
Cap. Flow
+$1.2B
Cap. Flow
% of AUM
1.25%
Top 10 Holdings %
Top 10 Hldgs %
33.93%
Holding
280
New
10
Increased
138
Reduced
66
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$363M |
| 2 |
JPMorgan Chase
JPM
|
+$363M |
| 3 |
American Airlines Group
AAL
|
+$310M |
| 4 |
CarMax
KMX
|
+$258M |
| 5 |
FedEx
FDX
|
+$191M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$779M |
| 2 |
DYAX
DYAX CORPORATION
DYAX
|
+$394M |
| 3 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$213M |
| 4 |
Bath & Body Works
BBWI
|
+$134M |
| 5 |
GSK
GSK
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.64% |
| 2 | Healthcare | 23.79% |
| 3 | Industrials | 15.28% |
| 4 | Consumer Discretionary | 9.12% |
| 5 | Financials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Insulet
PODD
$9.79B
| $172M | 0.18% |
5,194,369
-1,300
| -0% | -$40.8K |
|
102
Transocean
RIG
$5.82B
| $160M | 0.17% |
17,491,136
-358,800
| -2% | -$3.57M |
|
103
Merck
MRK
$318B
| $158M | 0.16% |
3,136,454
+212,534
| +7% | +$10.4M |
|
|
AFFX
104
DELISTED
Affymetrix Inc
AFFX
| $148M | 0.15% |
10,544,194
-353,546
| -3% | -$4.84M |
|
|
DFS
105
DELISTED
Discover Financial Services
DFS
| $145M | 0.15% |
2,856,600
+367,100
| +15% | +$17.7M |
|
106
C.H. Robinson
CHRW
$17.5B
| $136M | 0.14% |
1,832,654
-326,200
| -15% | -$22.4M |
|
107
RTX Corp
RTX
$301B
| $131M | 0.14% |
2,075,075
+3,972
| +0.2% | +$230K |
|
108
Applied Materials
AMAT
$428B
| $130M | 0.13% |
6,128,155
+45,400
| +0.7% | +$828K |
|
109
Las Vegas Sands
LVS
$29.6B
| $129M | 0.13% |
2,502,481
+326,000
| +15% | +$14.9M |
|
110
Rambus
RMBS
$11B
| $128M | 0.13% |
9,333,022
+8,700
| +0.1% | +$108K |
|
111
Rockwell Automation
ROK
$49B
| $126M | 0.13% |
1,110,700
-447,240
| -29% | -$45.4M |
|
112
Comscore
SCOR
$109M
| $126M | 0.13% |
209,627
+16,135
| +8% | +$11.7M |
|
113
MarketAxess Holdings
MKTX
$5.72B
| $125M | 0.13% |
1,003,420
| – | – |
|
114
CSX Corp
CSX
$93.1B
| $123M | 0.13% |
14,381,850
+685,050
| +5% | +$5.56M |
|
115
Northern Trust
NTRS
$33.9B
| $116M | 0.12% |
+1,775,400
| New | +$111M |
|
116
Apple
AAPL
$4.57T
| $113M | 0.12% |
4,162,000
-10,000
| -0.2% | -$249K |
|
|
ASNA
117
DELISTED
Ascena Retail Group, Inc.
ASNA
| $113M | 0.12% |
512,105
+3,695
| +0.7% | +$652K |
|
118
Tyson Foods
TSN
$20.4B
| $110M | 0.11% |
1,656,100
+16,100
| +1% | +$968K |
|
|
IMGN
119
DELISTED
Immunogen Inc
IMGN
| $110M | 0.11% |
12,867,483
| – | – |
|
120
IDEX
IEX
$17.3B
| $109M | 0.11% |
1,319,810
+1,700
| +0.1% | +$127K |
|
|
EA
121
DELISTED
Electronic Arts
EA
| $108M | 0.11% |
1,638,825
-90,025
| -5% | -$5.74M |
|
|
POT
122
DELISTED
Potash Corp Of Saskatchewan
POT
| $108M | 0.11% |
6,337,259
-726,074
| -10% | -$12.2M |
|
123
Pentair
PNR
$11B
| $107M | 0.11% |
2,942,413
-342,470
| -10% | -$11.1M |
|
|
ABAX
124
DELISTED
Abaxis Inc
ABAX
| $107M | 0.11% |
2,347,500
+1,500
| +0.1% | +$66.7K |
|
125
Curtiss-Wright
CW
$25.5B
| $104M | 0.11% |
1,376,900
+72,250
| +6% | +$5.01M |
|
Similar funds
VAM
Primecap Management's Q1 2016 Portfolio in Review
As of Q1 2016, Primecap Management held 280 positions worth $96.4B, down 1.4% from $97.8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Primecap Management's Q1 2016 filing shows 10 new, 138 increased, 66 reduced and 10 closed positions. Its largest new stake was Northern Trust: 1,775,400 shares worth $116M. The largest sale was Johnson & Johnson, an estimated $779M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q1 2016 buy was Northern Trust: 1,775,400 shares worth $116M.
- Primecap Management added most to AstraZeneca in Q1 2016, an estimated $363M increase.
- Primecap Management's biggest Q1 2016 reduction was Johnson & Johnson, cutting an estimated $779M.
- Primecap Management fully exited DYAX CORPORATION in Q1 2016, selling an estimated $394M.
- Primecap Management's ten largest holdings make up 34% of its $96.4B portfolio in Q1 2016.
- Primecap Management opened 10 new positions and closed 10 in Q1 2016.
- Primecap Management's portfolio value fell 1.4% quarter-over-quarter to $96.4B.
Based on Primecap Management's 13F filing for Q1 2016, filed 12 May 2016.